Your Patients' Gums Are Killing Them Silently - And You're Missing the Revenue in It

A five-operatory general practice collecting right around a million dollars a year is almost certainly leaving $70,000 of high-margin, recurring production on the table, and it's sitting in the hygiene schedule under the code D1110. Nearly half of all U.S. adults over 30 have periodontitis, per the CDC, and roughly 8% have the severe form. Look at your own hygiene production mix. If periodontal therapy isn't somewhere north of 15% of it, your charts and the epidemiology are telling two different stories, and the epidemiology isn't the one that's wrong.

Here's the part owners will argue with: this is not a case-acceptance problem, and it is not a patient-education problem. It's an accountability problem, and the fix is to pay hygienists on periodontal diagnosis and therapy production. Most practice consultants will tell you that's a malpractice invitation and an overtreatment engine. Our view: the undertreatment you have right now is the bigger clinical and financial liability, and a measured incentive tied to probing compliance is the only intervention we've seen actually move the number.

Forty-Two Percent in the Charts, Eight Percent on the Schedule

The American Dental Association puts periodontitis prevalence at roughly 42% of dentate adults 30 and older, drawing on NHANES 2009 to 2014 data, with prevalence climbing sharply by age and running meaningfully higher in men and in non-Hispanic Black and Hispanic populations. That's not a fringe finding. It's the clinical baseline for every general practice with an adult recall base.

Now run the arithmetic on your own patient list. A practice with 1,500 active adult patients over 30 should expect roughly 630 of them to have periodontitis.

About 120 of those should have the severe form.

Pull your D4910 count. Pull the number of unique patients who had scaling and root planing in the last 24 months. In most practices we look at, the combined figure is a small fraction of what the prevalence data predicts, and the gap isn't explained by a uniquely healthy patient base in a suburb of 40,000 people.

Forty-two percent of your adult chairs have a disease and your schedule says eight percent do. One of those numbers is wrong, and it isn't the CDC's.

What Most Owners Get Wrong: Calling It a Case-Acceptance Problem

The owner who notices a thin perio number almost always diagnoses it as a conversion failure. They buy an intraoral camera, order a patient-education module, send the lead hygienist to a two-day course on "perio verbal skills," and wait for acceptance to climb. It doesn't, because the problem is upstream of the conversation.

You cannot have a case-acceptance problem on a case that was never diagnosed. And a diagnosis cannot happen without a six-point full-mouth probing recorded in the chart, which is the single step that gets skipped when a hygienist has 50 minutes, a patient who wants to talk about their vacation, and a doctor who is going to walk in for a 90-second exam and say "looks good." The missing input isn't persuasion. It's data collection.

The second mistake belongs to the owner who did build a perio program and then let it rot. They converted 80 patients to three-month maintenance in 2023, and by 2026 half of those patients have quietly drifted back to a six-month prophy because the front desk books whatever interval the software defaults to and nobody audits it. Perio reversion is invisible on a production report. It only shows up as a hygiene department that stopped growing.

Both mistakes share a root cause: no single person in the building owns the number. The doctor owns the diagnosis legally but isn't in the room for the probing. The hygienist does the probing but has no stake in what it reveals. The front desk controls the interval and knows nothing about staging. That's three people, zero owners, and a 42% disease prevalence quietly converting into adult prophy codes.

The $72,600 Gap in a Five-Operatory Practice

Take a practice that looks like the middle of the market. Per the Practice Market Index, our dataset of 925 dental practices currently listed for sale, the median practice on the market has 5 operatories (n=754) and produces a median of $200,000 in collections per operatory (n=643). Those are figures from the asking side of the market, not a census of every practice in America, but as a production yardstick for a five-chair general office, a million dollars a year is a fair place to stand.

Assume this practice has 1,500 active adults over 30 and currently has 90 patients on periodontal maintenance. Prevalence says it should be identifying hundreds. Set a deliberately conservative target: convert 60 previously undiagnosed patients to active periodontal therapy over the next 12 months, which is 5 cases a month and well under 10% of the estimated gap.

At an assumed $250 per quadrant for scaling and root planing, a full-mouth case is $1,000, and 60 cases is $60,000 in year-one therapy production.

Then the recurring layer. Those 60 patients move from two prophys a year at an assumed $105 to three maintenance visits a year at an assumed $140. That's $420 a year instead of $210, an incremental $210 per patient.

Across 60 patients that's $12,600 of additional annual hygiene revenue that renews without any new marketing spend.

Year one totals $72,600, which is 36% of what one of this practice's operatories produces in a year, added without building a room, hiring a dentist, or buying a single new patient.

Run the same conversion rate for four years and the recurring base alone compounds to 240 patients and $50,400 a year in incremental hygiene revenue, before you count the therapy production stacked on top.

Now the cost side, because perio therapy is sometimes dismissed as a chair-time loser. BLS OEWS data for May 2023 puts national dental hygienist employment at 211,630 with a mean annual wage of $89,890 and a median of $87,530. At the mean, that's about $43 an hour of base wage.

Load it 20% for payroll taxes and benefits and you're at roughly $52 an hour.

Deliver that $1,000 full-mouth case across two 60-minute appointments and the direct clinical labor is about $104.

Add anesthetic, instruments, sterilization, and an irrigant and you're still clearing the overwhelming majority of the fee as contribution margin. This is the highest-margin recurring service a general practice owns, and it's the one most commonly left undiagnosed.

Why $72,600 Matters More in 2026 Than It Did in 2019

The margin environment is why this stopped being an optional project. Reporting on ADA Health Policy Institute data, Dental Economics notes that average GP net income was $207,980 in 2024, while comparing 2015 to 2019 against 2020 to 2024, average per-dentist revenue actually fell 1.2%, from $706,966 to $698,436, and practice expenses rose 3% to $482,343.

That's an $8,530 revenue decline per dentist against rising costs.

The $72,600 scenario above covers that revenue shortfall more than eight times over, and it does it with production that carries far better margin than a crown.

Owners facing this squeeze mostly reach for fee increases, PPO renegotiation, or more new patients. Those are all real levers and all slower and more expensive than correctly diagnosing the patients already sitting in your chairs twice a year. We wouldn't spend another dollar on new-patient acquisition before auditing perio diagnosis. The cheapest patient in dentistry is the one you already have and have been undertreating since 2021.

The Cancer Statistic That Should Be in Your Perio Conversation

There's also a clinical argument that most practices are underusing, and it reframes periodontal therapy from a billing upgrade into medicine. The American Academy of Periodontology cites research finding that men with gum disease were 49% more likely to develop kidney cancer, 54% more likely to develop pancreatic cancer, and 30% more likely to develop blood cancers.

Those are association findings, not proof of causation, and a practice that overstates them deserves the complaint it gets. But a patient who shrugged off "you have some bleeding" will sit up for "this is a chronic inflammatory disease that shows up in the research alongside pancreatic cancer risk, and here's your bleeding score." That's the difference between selling a deep cleaning and explaining a diagnosis. It also opens the door to the medical cross-referral relationships that almost no general practice bothers to build, particularly with endocrinology and cardiology.

Why We'd Pay on Perio Anyway

Back to the thesis, because this is where we part ways with the consulting consensus. The standard objection to incentivizing hygienists on periodontal production is that you'll manufacture disease. It's a fair risk and it's the wrong thing to optimize against, because the current state of most practices is manufacturing health, which is worse.

Structure it so the incentive rides on the input, not the verdict. Pay on full-mouth probing compliance and documentation completeness, measured as the share of adult recall visits with a recorded six-point chart and a staging note. Hit 95% and the bonus pays whether the diagnosis came back as healthy, gingivitis, or stage III. You're buying data collection, not diagnoses. The doctor still owns the call, every conversion still needs a signed diagnosis in the chart, and you audit a random sample of ten charts a month against the radiographs.

Do that and the perio number rises on its own, because the disease was always there. We'd take that structure over a verbal-skills seminar every single time.

Three Numbers to Pull This Week

Run a report on the last 12 months and get three figures: periodontal therapy as a percentage of total hygiene production, the count of unique patients with any D4341 or D4342 in 24 months, and the share of adult recall visits with a complete six-point probing in the chart. If that last number is below 80%, stop there, because nothing downstream will work until the probing is happening. Then set a probing-compliance target, tie a modest quarterly bonus to it, and recheck the perio percentage in 90 days.

If you want to see how much of that $72,600 your current cost structure would actually keep, benchmark your overhead first. Our free run your own numbers overhead calculator breaks out hygiene department cost against hygiene production, which is the specific line that tells you whether a perio build-out drops to the bottom line or gets eaten by chair time.

What we're watching next: whether practices that bonus on probing compliance show elevated reversion from maintenance back to prophy at the 24-month mark, which would suggest the diagnoses weren't holding up. If that pattern shows up in enough offices, we'll change our call on incentive design. We're also tracking how many practices coming onto the market show a hygiene mix consistent with the 42% prevalence figure, because a prophy mill is a correctable problem for a buyer and an invisible one for a seller.